Filing Details

Accession Number:
0001235802-19-000141
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-23 16:16:00
Reporting Period:
2019-12-20
Accepted Time:
2019-12-23 16:16:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492658 Wright Medical Group N.v. WMGI Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 980509600
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550508 Julie Andrews 1023 Cherry Road
Memphis TN 38117
Svp, Global Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-12-20 9,000 $19.36 41,715 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Disposition 2019-12-20 7,001 $30.10 34,714 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2019-12-20 9,000 $0.00 9,000 $19.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,618 2022-05-18 No 4 M Direct
Footnotes
  1. Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.08 to $30.125, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. This option has fully vested.